Xtant Medical

2017 Press Releases

Webcast ImageClick here for Webcast
Q1 2017 Xtant Medical Holdings Inc Earnings Conference Call (Replay)
05/10/17 at 10:00 a.m. ET
Q1 2017 Xtant Medical Holdings Inc Earnings Conference Call
Wednesday, May 10, 2017 10:00 a.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Keyword Search
 
2017 | 2016 | 2015 | 2014 | 2013

Xtant Medical Announces Rescheduling of Annual Meeting

05/26/17

BELGRADE, Mont., May 26, 2017 (GLOBE NEWSWIRE) -- Xtant™ Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development of regenerative medicine products and medical devices, today announced that its board of directors has rescheduled the Comp...

Read More

Xtant Medical Enters into Licensing Agreement for Sites Medical’s OsteoSync Ti Technology

05/16/17

BELGRADE, Mont., May 16, 2017 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development, manufacturing and marketing of orthopedic products for domestic and international markets, today announced it has entered i...

Read More

Xtant Medical Announces OrbiMed Financing and Engagement of Aurora Management Partners

05/12/17

BELGRADE, Mont., May 12, 2017 (GLOBE NEWSWIRE) -- Xtant™ Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development of regenerative medicine products and medical devices, today announced it has entered into an amendment to its senior credi...

Read More

Xtant™ Medical Reports First Quarter Revenue of $22.1 million, 5% Growth Compared to the Prior Year Period

05/09/17

First Quarter 2017 Highlights: Consolidated total revenue increased 5.3% to $22.1 million compared to first quarter 2016 revenue of $21.0 million Consolidated gross profit increased 10.1% to $15.5 million compared to first quarter 2016 gros...

Read More

Xtant Medical Sets Annual Meeting and Record Dates

05/05/17

BELGRADE, Mont., May 05, 2017 (GLOBE NEWSWIRE) -- Xtant™ Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development of regenerative medicine products and medical devices, has established a record date for its 2017 annual meeting of stockho...

Read More

Xtant Medical Announces Release of First Quarter 2017 Results on May 9, 2017

05/01/17

BELGRADE, Mont., May 01, 2017 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development of regenerative medicine products and medical devices, announced that it will release its financial results for the First Qu...

Read More

Xtant Medical Recognized as Montana Ambassador Business of the Year

04/25/17

BELGRADE, Mont., April 25, 2017 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development, manufacturing and marketing of orthopedic products for domestic and international markets, today announced it has been na...

Read More

Xtant™ Medical Receives Going Concern Opinion

04/05/17

BELGRADE, Mont., April 05, 2017 (GLOBE NEWSWIRE) -- Xtant™ Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development of regenerative medicine products and medical devices, today announced that as previously disclosed in its Annual Report ...

Read More

Xtant™ Medical Reports Record Fourth Quarter Revenue of $24.5 million, 10% Growth Compared to Prior Year Period

03/09/17

See footnote about the use of pro forma financial information Fourth Quarter 2016 Highlights: Consolidated total revenue increased 9.9% to a record $24.5 million compared to fourth quarter 2015 revenue of $22.3 million Consolidated gross p...

Read More

Xtant Medical to announce Fourth Quarter and Full Year 2016 Results on March 9th, 2017

03/01/17

BELGRADE, Mont., March 01, 2017 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development of regenerative medicine products and medical devices, today announced that it will release its financial results for the ...

Read More

Xtant Medical Announces Appointment of Carl O'Connell to Permanent CEO

02/22/17

BELGRADE, Mont., Feb. 22, 2017 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development of regenerative medicine products and medical devices, today announced the appointment of Carl O’Connell as the permanent C...

Read More

Xtant Medical CEO Dan Goldberger announces resignation

01/23/17

BELGRADE, Mont., Jan. 23, 2017 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development, manufacturing and marketing of orthopedic products for domestic and international markets, today announced that on January...

Read More

XTNT Announces Issuance of PIK Notes

01/19/17

BELGRADE, Mont., Jan. 19, 2017 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development, manufacturing and marketing of orthopedic products for domestic and international markets, today has announced the issuanc...

Read More

XTNT Announces Closing of Registered Direct Offering

01/18/17

BELGRADE, Mont., Jan. 18, 2017 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development, manufacturing and marketing of orthopedic products for domestic and international markets, today has announced the closing...

Read More

XTNT Announces Registered Direct Offering

01/13/17

BELGRADE, Mont., Jan. 13, 2017 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development, manufacturing and marketing of orthopedic products for domestic and international markets, today has announced that it has...

Read More

XTNT Announces Preliminary Fourth Quarter and Full Year 2016 Revenue & Adjusted EBITDA

01/11/17

Record Fourth Quarter 2016 Revenue is estimated to be at least $24.5 million which represents 10.0% year on year growth Full Year 2016 Revenue is estimated to be at least $90.0 million which represents 4.1% year on year growth Fourth Quarte...

Read More